EP0034116A3 — N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
Assigned to Berlex Laboratories Inc · Expires 1981-09-02 · 45y expired
What this patent protects
3-Phenoxy-2-hydroxypropylamines having an N-ben zimidazolylalkyl substituent and similar compounds are described herein. They are obtained by the reaction of the appropriate imidazole-1-alkanamine with an epoxide and they are β-adrenergic blocking agents.
USPTO Abstract
3-Phenoxy-2-hydroxypropylamines having an N-ben zimidazolylalkyl substituent and similar compounds are described herein. They are obtained by the reaction of the appropriate imidazole-1-alkanamine with an epoxide and they are β-adrenergic blocking agents.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.